US HB2500 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on April 6 2023 - 25% progression, died in committee
Action: 2023-04-14 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 6 2023 - 25% progression, died in committee
Action: 2023-04-14 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes.
Title
Protecting Americans from Unsafe Drugs Act of 2023
Sponsors
Sen. Andy Kim [D-NJ] | Rep. John Sarbanes [D-MD] |
History
Date | Chamber | Action |
---|---|---|
2023-04-14 | House | Referred to the Subcommittee on Health. |
2023-04-06 | House | Referred to the House Committee on Energy and Commerce. |
2023-04-06 | House | Introduced in House |
Same As/Similar To
HB4697 (Related) 2023-07-21 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/2500/all-info |
Text | https://www.congress.gov/118/bills/hr2500/BILLS-118hr2500ih.pdf |